NOD-Like Receptors: Innate Immunity Explained

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-09-20

NOD-like receptors (NLRs) are a family of cytosolic pattern recognition receptors that detect microbial molecules and cellular danger signals inside the host cell and convert that detection into inflammatory signaling. They sit downstream of the cell surface, which means they answer a different question than Toll-like receptors: not "is there a microbe outside the cell" but "has something breached the membrane or disturbed the cytoplasm."

That distinction matters clinically. Many of the pathogens that cause the most economically important disease in cattle, pigs, poultry, and companion animals are facultative intracellular organisms or toxin producers that spend part of their life cycle in the cytosol. NLRs are the sensors that catch them there. When NLR signaling is too weak, animals fail to clear infection. When it is too strong or inappropriately triggered, the result is sterile inflammation and tissue damage. Both failure modes appear in veterinary medicine, and both are now understood at the level of individual receptor domains.

Why NLRs Matter in Veterinary Medicine

The innate immune system has to solve a detection problem. Extracellular receptors such as TLR4 sample the outside of the cell. Intracellular pathogens, including Salmonella enterica serovar Typhimurium, Listeria monocytogenes, and Bacillus anthracis, can evade surface detection by entering the cytosol or by remodeling the phagosome. NLRs patrol that compartment. NOD1 and NOD2 recognize peptidoglycan fragments from both Gram-negative and Gram-positive bacteria, and their activation is required for full proinflammatory cytokine output during infection [1]. Mice lacking both receptors show impaired tumor necrosis factor alpha, interleukin-1 alpha, interleukin-1 beta, CCL5, interleukin-6, and KC production after B. anthracis exposure, and they mount weaker anamnestic antibody responses after aerosol challenge [2].

The second reason NLRs matter is that they are not purely microbial sensors. NOD1 and NOD2 respond to perturbations of the actin cytoskeleton, to endoplasmic reticulum stress, and to viral and parasitic infections, which broadens their role well beyond peptidoglycan detection [3]. This has direct implications for how we interpret inflammation in animals where no bacterial pathogen is cultured.

The NLR Family: A Structural Map

Every NLR shares a common architecture. The name comes from the central nucleotide-binding oligomerization domain, often called the NACHT domain, which is the engine of the protein. At the N-terminus sits a variable effector domain that determines what the receptor does once activated. At the C-terminus sits a leucine-rich repeat region that typically acts as the autoinhibitory and ligand-sensing module.

The N-terminal domain defines the functional subfamilies:

• CARD-containing NLRs. NOD1 and NOD2 carry caspase activation and recruitment domains. These recruit the kinase RIP2 and drive NF-kB and MAPK signaling.
• PYD-containing NLRs. NLRP3 and related proteins carry a pyrin domain. These assemble inflammasomes by recruiting the adaptor ASC through pyrin-pyrin interactions.
• BIR-containing NLRs. NAIP proteins carry baculovirus inhibitor of apoptosis repeat domains and partner with NLRC4 to detect bacterial flagellin and type III secretion apparatus components.
• ALRs. The AIM2-like receptors are a structurally related but distinct family. AIM2 is not an NLR. It is a PYHIN-family protein that senses double-stranded DNA directly and forms an inflammasome with ASC and caspase-1. Students frequently group AIM2 with NLRs because the downstream output is identical, but the ancestry and the ligand are different.

This structural logic explains a common exam trap. Not every NLR forms an inflammasome, and not every inflammasome-forming sensor is an NLR.

Sensor NLRs Versus Inflammasome-Forming NLRs

The cleanest way to organize the family is by output.

Sensor NLRs activate transcriptional programs. NOD1 and NOD2 are the canonical examples. They detect peptidoglycan fragments, recruit RIP2, and activate NF-kB, which drives transcription of proinflammatory cytokines, chemokines, type I interferons, and antimicrobial peptides [4]. The response is graded and sustained. It shapes the tissue environment.

Inflammasome-forming NLRs activate a protease cascade. NLRP3 oligomerizes with ASC and pro-caspase-1 into a multiprotein complex. Caspase-1 then cleaves pro-interleukin-1 beta and pro-interleukin-18 into their active forms and cleaves gasdermin D, which forms membrane pores and triggers pyroptosis, a lytic inflammatory cell death [5]. The response is fast, local, and destructive.

The two systems are not mutually exclusive. NOD1 and NOD2 signaling can prime NLRP3 by inducing pro-interleukin-1 beta transcription through NF-kB, and a second signal then triggers inflammasome assembly. This two-signal model is a core concept in innate immunology.

NOD1 and NOD2: Peptidoglycan Sensing Step by Step

Peptidoglycan is the mesh-like polymer that gives bacterial cell walls their shape. It is composed of glycan strands cross-linked by short peptides. The fragments that NOD1 and NOD2 detect are called muropeptides.

1. Ligand generation. Bacterial peptidoglycan is degraded by host lysozymes and bacterial enzymes into soluble fragments. NOD1 senses fragments containing a diaminopimelic acid residue, which is characteristic of Gram-negative bacteria and some Gram-positive bacilli. NOD2 senses muramyl dipeptide, the minimal common motif found in essentially all bacterial peptidoglycan [4].
2. Delivery to the cytosol. Fragments reach the cytosol through peptide transporters, endosomal escape, or bacterial secretion systems. This step is rate-limiting and is why NOD signaling depends on the pathogen reaching the right compartment.
3. Membrane recruitment. NOD1 and NOD2 must be recruited to bacteria-containing endosomes and other intracellular membranes. This recruitment requires S-palmitoylation, a lipid modification added by the enzyme ZDHHC5. Disease-associated NOD2 mutations that disrupt palmitoylation impair bacterial sensing, which links a specific posttranslational modification to inflammatory disease susceptibility [6].
4. RIP2 recruitment and ubiquitination. Once ligand-bound, NOD1 and NOD2 oligomerize and recruit RIP2 through CARD-CARD interactions. RIP2 is ubiquitinated, which scaffolds the IKK complex and the MAPK cascade.
5. NF-kB and MAPK activation. The IKK complex phosphorylates IkB, freeing NF-kB to enter the nucleus. MAPK pathways activate AP-1. Together they drive cytokine and chemokine transcription [7].
6. Amplification and crosstalk. NOD1 and NOD2 signaling synergizes with TLR signaling. In dendritic cells, NOD1 and NOD2 cooperate with TLR4 to potentiate interleukin-12 production, which in turn activates invariant NKT cells and drives interferon-gamma output during Salmonella and Listeria infection [8].

A non-apoptotic role for the BCL2 family protein BID has been identified in this pathway. BID interacts with NOD1, NOD2, and the IKK complex, and cells depleted of BID are defective in cytokine production after NOD activation [9]. This is a reminder that NLR signaling is not a simple linear cascade but a network that intersects with apoptosis machinery.

The NLRP3 Inflammasome

NLRP3 is the most studied inflammasome sensor and the most relevant to veterinary inflammatory disease. Its activation requires two signals.

Signal 1 (priming) is transcriptional. NF-kB activation, often downstream of TLR or NOD1/NOD2 signaling, increases NLRP3 and pro-interleukin-1 beta expression.

Signal 2 (activation) is posttranslational. A diverse set of stimuli triggers NLRP3 oligomerization, ASC recruitment, and caspase-1 activation. These include potassium efflux, reactive oxygen species accumulation, lysosomal damage, and mitochondrial DNA release [10][11].

The output is threefold: mature interleukin-1 beta, mature interleukin-18, and pyroptosis. Interleukin-1 beta is a potent pyrogen and drives fever, leukocyte recruitment, and acute phase responses. Interleukin-18 amplifies interferon-gamma production. Pyroptosis releases intracellular contents that further amplify inflammation.

The breadth of NLRP3 stimuli is striking. Bacterial toxins, uric acid crystals, asbestos, and aluminum hydroxide adjuvants all activate it [10]. This is why NLRP3 is described as a sensor of cellular perturbation rather than a sensor of a single molecular pattern. In fish, nervous necrosis virus activates NLRP3 through mitochondrial DNA release and oxidative DNA damage, and the interaction between NLRP3 and ASC is required for inflammasome assembly [11].

Summary Table

Signaling Flow

The following flowchart traces the main decision path from pathogen entry to inflammatory output.

flowchart TD
    A[Pathogen enters cell] --> B{Location of signal}
    B -->|Cytosol peptidoglycan| C[NOD1 or NOD2]
    B -->|Cytosol DNA| D[AIM2]
    B -->|Cellular stress| E[NLRP3]
    C --> F[RIP2 recruitment]
    F --> G[NF-kB activation]
    G --> H[Cytokine transcription]
    G --> I[NLRP3 priming]
    E --> J[Inflammasome assembly]
    I --> J
    J --> K[Caspase-1 activation]
    K --> L[IL-1 beta and IL-18 release]
    K --> M[Pyroptosis]

How NLR Signaling Is Observed in Practice

NLR activity is not measured directly in routine veterinary diagnostics. It is inferred from downstream markers.

Cytokine assays. Interleukin-1 beta and interleukin-18 are measured by ELISA in serum, synovial fluid, or tissue homogenate. Elevated levels suggest inflammasome activation but do not identify the specific sensor.

Histopathology. Pyroptosis produces a characteristic morphology with cell swelling, membrane rupture, and surrounding neutrophilic inflammation. In endodontic and periodontal disease models, NLR-mediated immunity drives pulpal inflammation and periapical bone resorption [12].

Gene expression. Quantitative PCR for NLRP3, ASC, caspase-1, NOD1, and NOD2 is used in research settings. In a rat model of pulmonary arterial hypertension, intermittent hypoxia increased NLRP3, caspase-1, and ASC protein expression alongside interleukin-1 beta and interleukin-18, and both an ROS inhibitor and an NLRP3 inhibitor reversed these effects [5].

Pharmacologic probes. MCC950 is a small-molecule NLRP3 inhibitor used experimentally. N-acetylcysteine is used to test whether reactive oxygen species are upstream of inflammasome activation [5]. These are research tools, not clinical treatments.

Genetic approaches. Knockout mice lacking Nod1 and Nod2 are used to establish receptor requirements in infection models [2]. Genome-wide RNA interference screens have identified novel pathway components such as BID [9].

Comparative Species Notes

NLR repertoires differ substantially across vertebrates, and these differences have practical consequences for disease susceptibility and for the validity of animal models.

Cattle. Cattle have an expanded NLR repertoire relative to humans and mice. This expansion is consistent with the broad range of intracellular and extracellular pathogens that cattle encounter, and it suggests that bovine innate immunity relies more heavily on cytosolic surveillance than some other species. The practical implication is that bovine NLR biology cannot be assumed from mouse data.

Pigs. Porcine NLRP3 shows distinct activation behavior compared with human and murine NLRP3. Pigs are a major reservoir for influenza viruses and other respiratory pathogens, and inflammasome-driven interleukin-1 beta responses shape the severity of porcine respiratory disease. The functional differences mean that porcine-specific reagents and models are needed for accurate study.

Poultry. Poultry NLRP3 behavior is distinct from mammalian NLRP3, and the chicken genome encodes a different complement of NLR genes. This matters for interpreting vaccine adjuvant responses and for understanding why some inflammatory diseases present differently in birds.

Fish. NLRP3 is functionally conserved in teleosts. In grouper cells, nervous necrosis virus activates NLRP3 through mitochondrial DNA release and oxidative DNA damage, and the NLRP3-ASC interaction is required for inflammasome assembly [11]. This demonstrates that the core inflammasome architecture predates the divergence of mammals and fish.

Amphibians. The Chinese spiny frog genome contains 66 NLR genes, classified into three phylogenetic groups. Dispersed duplication was the main contributor to this expansion, and several duplicated gene pairs showed evidence of sequence divergence after duplication [13]. This is a useful reminder that NLR repertoire size varies enormously across vertebrates.

Human Autoinflammatory Disease as Comparative Context

Gain-of-function mutations in NLRP3 cause cryopyrin-associated periodic syndromes, a group of autoinflammatory diseases characterized by recurrent fever, urticaria, and systemic inflammation without an infectious trigger. These conditions demonstrate that a single receptor can drive disease when its activation threshold is lowered. The same principle applies in veterinary medicine. When NLRP3 is chronically activated by sterile triggers such as urate crystals or by persistent cellular stress, the result is tissue damage in the absence of a culturable pathogen.

Loss-of-function NOD2 mutations are associated with Crohn's disease in humans, and NOD1 and NOD2 mutations that disrupt membrane localization are linked to inflammatory bowel disease and other inflammatory conditions [6]. The parallel in veterinary medicine is chronic enteropathy in dogs and cats, where impaired bacterial sensing may contribute to dysregulated mucosal inflammation.

Clinical Relevance, Limitations and Common Mistakes

Clinical relevance. NLR signaling is central to how animals respond to intracellular bacteria, viruses, and sterile danger signals. It shapes vaccine adjuvant responses, the severity of respiratory and enteric disease, and the progression of inflammatory conditions including periodontal disease and pulmonary hypertension. Understanding NLR biology helps explain why some infections produce disproportionate inflammation and why some animals fail to clear pathogens despite appropriate antimicrobial therapy.

Limitations. NLR activity is not measured in routine diagnostic panels. Cytokine measurements are research tools. Species differences in NLR repertoire and function mean that findings from one species cannot be directly extrapolated to another. Individual cases require veterinary assessment, and treatment decisions should be based on clinical examination, laboratory data, and the veterinarian's judgment.

Common mistakes.

• Confusing sensor NLRs with inflammasome-forming NLRs. NOD1 and NOD2 drive transcription. NLRP3 drives protease activation and cell death.
• Classifying AIM2 as an NLR. AIM2 is an ALR-family DNA sensor that forms an inflammasome but is structurally distinct.
• Assuming NLRP3 responds to a single ligand. It responds to a wide range of cellular perturbations.
• Ignoring the two-signal requirement for NLRP3. Priming and activation are separate steps.
• Extrapolating mouse NLR data directly to cattle, pigs, or poultry. Repertoire and function differ.
• Overlooking the role of posttranslational modifications. Palmitoylation is required for NOD1 and NOD2 membrane recruitment and signaling [6].

Quick Review

1. NLRs are cytosolic pattern recognition receptors that detect microbial and danger signals inside the cell.
2. NOD1 senses diaminopimelic acid-containing peptidoglycan fragments. NOD2 senses muramyl dipeptide.
3. Both NOD1 and NOD2 signal through RIP2 to activate NF-kB and MAPK.
4. NLRP3 forms an inflammasome with ASC and caspase-1, releasing interleukin-1 beta and interleukin-18 and causing pyroptosis.
5. AIM2 is an ALR-family DNA sensor, not an NLR, but it uses the same inflammasome adaptor.
6. NLRP3 activation requires priming (transcriptional) and activation (posttranslational) signals.
7. NLR repertoires differ across species, with cattle showing expansion and pigs and poultry showing distinct NLRP3 behavior.

This article is educational and is not a substitute for veterinary diagnosis or treatment.

Frequently Asked Questions

What is the difference between NOD1 and NOD2?

NOD1 detects peptidoglycan fragments containing diaminopimelic acid, which is found mainly in Gram-negative bacteria. NOD2 detects muramyl dipeptide, which is present in nearly all bacterial peptidoglycan. Both signal through RIP2 to NF-kB.

Can NLRs detect viruses?

Yes. NOD1 and NOD2 respond to viral infections and to cellular stress caused by infection, including endoplasmic reticulum stress [3][14]. NLRP3 is activated by several viruses through mechanisms including mitochondrial DNA release and reactive oxygen species accumulation [11].

Why does NLRP3 need two signals?

The first signal primes the cell by increasing NLRP3 and pro-interleukin-1 beta expression through NF-kB. The second signal triggers assembly of the inflammasome complex. This two-step design prevents accidental inflammasome activation.

What happens when NLRP3 is overactive?

Overactive NLRP3 causes excessive interleukin-1 beta release and pyroptosis, leading to tissue damage. In humans, gain-of-function NLRP3 mutations cause cryopyrin-associated periodic syndromes. In animals, chronic NLRP3 activation contributes to inflammatory conditions such as pulmonary hypertension and periodontal disease.

Do all animals have the same NLR genes?

No. Cattle have an expanded NLR repertoire compared with humans and mice. Pigs and poultry show distinct NLRP3 behavior. The Chinese spiny frog has 66 NLR genes [13]. Repertoire size and function vary widely across vertebrates.

Is NLR signaling involved in vaccine responses?

Yes. NOD1 and NOD2 agonists induce proinflammatory cytokines, type I interferons, and antimicrobial peptides, and they synergize with TLR agonists [4]. This makes NLR pathways relevant to adjuvant design and to understanding why some vaccines produce stronger inflammatory responses than others.

Related Articles

• Innate Immunity: Receptors and Effector Mechanisms
• Thymosin Alpha-1 (TA-1): Toll-Like Receptor Signaling, T-Cell Differentiation, Antiviral Immunomodulation, and Reconstitution
• Adaptive Immunity: B Cell and T Cell Responses
• Z-DNA Binding Protein 1: Structure, Function, and Role in Immunity
• Eimeria maxima: Midgut Coccidiosis in Chickens, Lesion Scoring and Immunity
• Dog Cough Like Honk

Sources

1. NOD1 and NOD2 Signaling in Infection and Inflammation.
2. Nod1/Nod2-mediated recognition plays a critical role in induction of adaptive immunity to anthrax after aerosol exposure.
3. NOD1 and NOD2: Beyond Peptidoglycan Sensing.
4. NOD1 and NOD2: Molecular targets in prevention and treatment of infectious diseases.
5. Mechanism of IH promoting pulmonary arterial hypertension through ROS-NLRP3 inflammasome mediated endothelial cell pyroptosis.
6. Palmitoylation of NOD1 and NOD2 is required for bacterial sensing.
7. Activation of Nod1 and Nod2 induces innate immune responses of prostate epithelial cells.
8. Nod1 and Nod2 enhance TLR-mediated invariant NKT cell activation during bacterial infection.
9. Non-apoptotic role of BID in inflammation and innate immunity.
10. The microbial and danger signals that activate Nod-like receptors.
11. NNV mediates the activation of the NLRP3 inflammasome through mtDNA release and oxidative DNA damage.
12. Expression, Regulation and Therapeutic Implications of Nod-Like Receptors in Endodontics: A Narrative Review.
13. Genome-wide characterization of NOD-like receptor genes links NLR repertoire evolution to spleen immune responses after Aeromonas hydrophila challenge in the Chinese spiny frog (Quasipaa spinosa).
14. NOD1 and NOD2 Activation by Diverse Stimuli: a Possible Role for Sensing Pathogen-Induced Endoplasmic Reticulum Stress.